Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma-Reference-Cited by-同舟云学术

Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma

Published:2021-01-15 Issue:5 Volume:10 Page:1562-1575
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Krebs Franziska K.¹²^ORCID,Trzeciak Emily R.¹,Zimmer Sophia¹,Özistanbullu Deniz³,Mitzel‐Rink Heidrun¹,Meissner Markus³,Grabbe Stephan¹,Loquai Carmen¹,Tuettenberg Andrea¹²

Affiliation:

1. Department of Dermatology University Medical Center of the Johannes Gutenberg‐University Mainz Germany

2. German Cancer Consortium (DKTK)Partner Site Mainz/Frankfurt am Main Mainz Germany

3. Department of Dermatology, Venereology and Allergology Johann Wolfgang Goethe University Frankfurt Germany

Funder

Deutschen Konsortium für Translationale Krebsforschung

Wilhelm Sander-Stiftung

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3710

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer

3. The checkpoint immunotherapy revolution: what started as a trickle has become a flood, despite some daunting adverse effects; new drugs, indications, and combinations continue to emerge;Alexander W;P T,2016

4. Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice

5. Biomarkers for Immune Checkpoint Inhibitors in Melanoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis;Frontiers in Immunology;2024-05-24

2. Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?;Pharmacology & Therapeutics;2024-04

3. The Role of the Microbiome in Immune Response;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

4. Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update;Expert Review of Molecular Diagnostics;2024-02